SVRA Savara Inc

Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases.

$1.05  -0.01 (-0.94%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/20/2002
Outstanding shares:  113,868,809
Average volume:  481,419
Market cap:   $120,700,938
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    805111101
ISIN:        US8051111016
Sedol:      
Valuation   (See tab for details)
PE ratio:   -4.99
PB ratio:   0.77
PS ratio:   0.00
Return on equity:   -29.28%
Net income %:   -2,272,250.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy